Clinical Trials Browser

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Nausea, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms

NCT00381862 2017-06-12

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Phase 2 Completed

54 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Nausea, Rectal Neoplasms, Vomiting, Colorectal Neoplasms

NCT00064272 2016-10-21

IRB 2003-551

Phase 2 Completed

180 enrolled

Nausea, Vomiting

NCT02787707 2016-06-03

Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting

Phase 2 Completed

69 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Phase 2 Completed

65 enrolled 14 charts

Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Phase 2 Unknown

80 enrolled

Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT00003817 2015-10-15

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Phase 2 Completed

700 enrolled

Nausea, Vomiting

NCT00954941 2015-06-25

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Phase 2 Completed

100 enrolled 7 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Nausea, Vomiting, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT02407600 2015-04-03

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Phase 2 Unknown

150 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Nausea, Vomiting

NCT00450853 2015-01-27

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients

Phase 2 Completed

31 enrolled

Vomiting

NCT01788605 2014-12-08

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

Phase 2 Unknown

65 enrolled

Other hematologic neoplasm

Vomiting, Hematologic Neoplasms

NCT02290470 2014-11-14

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Phase 2 Unknown

81 enrolled

Nausea, Vomiting

NCT02234466 2014-09-09

Preoperative Oral Dexamethasone to Improve Recovery After Surgery

Phase 2 Unknown

80 enrolled

Breast

Breast Neoplasms, Vomiting, Postoperative Nausea and Vomiting

NCT01012336 2012-10-10

Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin

Phase 2 Completed

89 enrolled 7 charts

Gynecologic

Ovarian Neoplasms, Vomiting

NCT00212602 2012-06-14

ONO-7436 Phase II Study in Japan

Phase 2 Completed

420 enrolled

Nausea, Neoplasms, Vomiting

NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Phase 2 Completed

GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT01046461 2012-02-17

RAD

Phase 2 Unknown

41 enrolled

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase 2 Completed

492 enrolled

Nausea, Vomiting

NCT00666783 2008-04-25

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients

Phase 2 Completed

208 enrolled

Vomiting